JP2025511758A5 - - Google Patents
Info
- Publication number
- JP2025511758A5 JP2025511758A5 JP2024559214A JP2024559214A JP2025511758A5 JP 2025511758 A5 JP2025511758 A5 JP 2025511758A5 JP 2024559214 A JP2024559214 A JP 2024559214A JP 2024559214 A JP2024559214 A JP 2024559214A JP 2025511758 A5 JP2025511758 A5 JP 2025511758A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263327757P | 2022-04-05 | 2022-04-05 | |
| US63/327,757 | 2022-04-05 | ||
| US202263478068P | 2022-12-30 | 2022-12-30 | |
| US63/478,068 | 2022-12-30 | ||
| PCT/EP2023/059054 WO2023194501A1 (en) | 2022-04-05 | 2023-04-05 | Treatment of myeloid disorders and acute leukemias targeting novel tumor specific antigens |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025511758A JP2025511758A (ja) | 2025-04-16 |
| JP2025511758A5 true JP2025511758A5 (https=) | 2026-04-13 |
| JPWO2023194501A5 JPWO2023194501A5 (https=) | 2026-04-13 |
Family
ID=86226509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024559214A Pending JP2025511758A (ja) | 2022-04-05 | 2023-04-05 | 新規腫瘍特異的抗原を標的とする骨髄性障害および急性白血病の処置 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4504784A1 (https=) |
| JP (1) | JP2025511758A (https=) |
| KR (1) | KR20250042204A (https=) |
| CN (1) | CN119317643A (https=) |
| AU (1) | AU2023250214A1 (https=) |
| CA (1) | CA3255414A1 (https=) |
| IL (1) | IL316118A (https=) |
| MX (1) | MX2024012390A (https=) |
| WO (1) | WO2023194501A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025113635A1 (zh) * | 2023-12-01 | 2025-06-05 | 上海祥耀生物科技有限责任公司 | 抗cd84抗体及其用途 |
| CN118440198B (zh) * | 2024-04-03 | 2024-11-15 | 武汉爱博泰克生物科技有限公司 | 抗人cd69蛋白的兔单克隆抗体及其应用 |
| CN120678778B (zh) * | 2025-05-12 | 2026-01-27 | 山东康盛医疗器械股份有限公司 | 药物组合物在弥漫大b细胞淋巴瘤治疗中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| US7750116B1 (en) | 2006-02-18 | 2010-07-06 | Seattle Genetics, Inc. | Antibody drug conjugate metabolites |
| MX379256B (es) | 2013-03-15 | 2025-03-10 | Regeneron Pharma | Moleculas biologicamente activas, conjugados de las mismas, y usos terapeuticos. |
| ES3063961T3 (en) * | 2014-02-14 | 2026-04-21 | Cellectis | Cells for immunotherapy engineered for targeting antigen present both on immune cells and pathological cells |
| WO2018002902A1 (en) | 2016-07-01 | 2018-01-04 | Glaxosmithkline Intellectual Property (No.2) Limited | Antibody-drug conjugates and therapeutic methods using the same |
| EP3793591A1 (en) * | 2018-05-17 | 2021-03-24 | Regeneron Pharmaceuticals, Inc. | Anti-cd63 antibodies, conjugates, and uses thereof |
| US12534532B2 (en) * | 2018-10-26 | 2026-01-27 | Crage Medical Co., Limited | CLL1-targeting antibody and application thereof |
| US20240180963A1 (en) * | 2021-04-05 | 2024-06-06 | Altheia Science S.R.L. | Diagnosis and treatment of myeloid disorders and acute leukemias using novel tumor specific antigens |
-
2023
- 2023-04-05 CA CA3255414A patent/CA3255414A1/en active Pending
- 2023-04-05 JP JP2024559214A patent/JP2025511758A/ja active Pending
- 2023-04-05 WO PCT/EP2023/059054 patent/WO2023194501A1/en not_active Ceased
- 2023-04-05 IL IL316118A patent/IL316118A/en unknown
- 2023-04-05 CN CN202380044838.8A patent/CN119317643A/zh active Pending
- 2023-04-05 KR KR1020247036862A patent/KR20250042204A/ko active Pending
- 2023-04-05 AU AU2023250214A patent/AU2023250214A1/en active Pending
- 2023-04-05 EP EP23719650.6A patent/EP4504784A1/en active Pending
-
2024
- 2024-10-04 MX MX2024012390A patent/MX2024012390A/es unknown